According to Grifols's latest financial reports the company's total liabilities are $14.25 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $14.00 B | 3.77% |
2021-12-31 | $13.49 B | 28.26% |
2020-12-31 | $10.52 B | 8% |
2019-12-31 | $9.74 B | 9.46% |
2018-12-31 | $8.90 B | 1.76% |
2017-12-31 | $8.74 B | 29.8% |
2016-12-31 | $6.73 B | -2.17% |
2015-12-31 | $6.88 B | -2.12% |
2014-12-31 | $7.03 B | 36.49% |
2013-12-31 | $5.15 B | 4.04% |
2012-12-31 | $4.95 B | -3.8% |
2011-12-31 | $5.15 B | 227.78% |
2010-12-31 | $1.57 B | 1.7% |
2009-12-31 | $1.54 B | 58.15% |
2008-12-31 | $0.97 B | 20.49% |
2007-12-31 | $0.81 B | 12.5% |
2006-12-31 | $0.72 B | -20.34% |
2005-12-31 | $0.90 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 592.80% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 537.66% | ๐บ๐ธ USA |
Baxter BAX | $19.80 B | 38.92% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $16.27 B | 14.15% | ๐บ๐ธ USA |